Coherus BioSciences
CHRS
#8703
Rank
โ‚ฌ0.19 B
Marketcap
1,29ย โ‚ฌ
Share price
3.52%
Change (1 day)
69.95%
Change (1 year)

Revenue for Coherus BioSciences (CHRS)

Revenue in 2026 (TTM): โ‚ฌ40.04 Million

According to Coherus BioSciences 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ41.09 Million. In 2025 the company made a revenue of โ‚ฌ35.89 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ69.95 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Coherus BioSciences from 2014 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ40.04 M11.55%
2025 โ‚ฌ35.89 M-48.68%
2024 โ‚ฌ69.95 M-69.94%
2023 โ‚ฌ0.23 B18.28%
2022 โ‚ฌ0.19 B-31.77%
2021 โ‚ฌ0.28 B-25.46%
2020 โ‚ฌ0.38 B21.71%
2019 โ‚ฌ0.31 B
2018 N/A-100%
2017 โ‚ฌ1.29 M-99.28%
2016 โ‚ฌ0.18 B557.82%
2015 โ‚ฌ27.47 M7.42%
2014 โ‚ฌ25.57 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚ฌ32.62 B 79,289.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ0.66 B 1,528.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ0.10 B 146.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚ฌ0.32 M-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA